Journal of Natural Products
ARTICLE
Table 3. NMR Spectroscopic Data (500 MHz, DMSO-d6) for
NMR (pyridine-d5, 125 MHz) are given in Tables 1 and 2, respectively;
(þ)-ESIMS m/z 1111 [M þ Na]þ; HRESIMS m/z 1111.5297
[M þ Na]þ (calcd for C53H84O23Na, 1111.5296).
Compounds 9 and 10a
9
10
Gordonoside N (6): white, amorphous powder; mp 238ꢀ239 °C;
[R]20D ꢀ4.8 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 204 (4.32) nm;
IR νmax 3396, 2939, 1731, 1674, 1434, 1365, 1223, 1160, 1077, 1047 cmꢀ1
;
position
δC
δH (J in Hz)
δC
δH (J in Hz)
1H NMR (pyridine-d5, 500 MHz) and 13C NMR (pyridine-d5, 125 MHz)
are given in Tables 1 and 2, respectively; (þ)-ESIMS m/z 1259
[M þ Na]þ; (ꢀ)-ESIMS m/z 1235 [M ꢀ H]ꢀ; HRESIMS m/z 1259.5672
[M þ Na]þ (calcd for C58H92O28Na, 1259.5667).
1
153.7
92.8
153.6
92.9
2
6.12 d (2.0)
6.13 d (3.0)
3
153.3
131.6
150.8
97.2
153.3
131.6
150.8
97.2
4
Gordonoside O (7): white, amorphous powder; mp 232ꢀ233 °C;
[R]20D ꢀ7.3 (c 0.07, MeOH); UV (MeOH) λmax (log ε) 204 (4.28),
276 (2.94) nm; IR νmax 3372, 2936, 1728, 1673, 1430, 1366, 1201, 1141,
5
6
6.15 d (2.0)
3.56 s
6.18 d (3.0)
3.57 s
1075, 1044 cmꢀ1; H NMR (pyridine-d5, 500 MHz) and 13C NMR
1
OMe-7
55.5
55.6
(pyridine-d5, 125 MHz) are given in Tables 1 and 2, respectively; (þ)-
ESIMS m/z 1259 [M þ Na]þ; HRESIMS m/z 1259.5667 [M þ Na]þ
(calcd for C58H92O28Na, 1259.5667).
OMe-8
60.1
3.59 s
60.1
3.61 s
10
20
30
40
50
60
100.6
73.2
4.82 d (7.5)
3.23 m
100.5
73.2
4.82 d (8.0)
3.21 m
Gordonoside P (8): white, amorphous powder; mp 227ꢀ228 °C;
76.3
3.32 m
76.3
3.30 m
[R]20D ꢀ12.5 (c 0.06, MeOH); UV (MeOH) λmax (log ε) 204 (4.29) nm;
IR νmax 3390, 2942, 1727, 1676, 1434, 1365, 1203, 1141, 1075, 1045 cmꢀ1
;
70.2
3.25 m
70.1
3.23 m
1H NMR (pyridine-d5, 500 MHz) and 13C NMR (pyridine-d5, 125 MHz)
are given in Tables 1 and 2, respectively; (þ)-ESIMS m/z 1273
[M þ Na]þ; (ꢀ)-ESIMS m/z 1249 [M ꢀ H]ꢀ; HRESIMS m/z 1273.5827
[M þ Na]þ (calcd for C59H94O28 Na, 1273.5824).
73.9
3.71 m
73.9
3.69 m
64.2
4.20 m
64.1
4.15 dd (12.0, 7.0)
4.57 d (12.0)
4.62 d (11.0)
70
100
200
300
400
500
600
165.6
119.3
107.0
147.6
140.9
147.6
107.0
56.1
165.6
120.4
112.6
147.5
151.8
115.3
123.7
55.6
1-O-3,4-Dimethoxy-5-hydroxyphenyl-(6-O-3,5-dimethoxygalloyl)-
β-D-glucopyranoside (9): white, amorphous powder; mp 132ꢀ133 °C;
[R]20D ꢀ50.7 (c 0.04, MeOH); UV (MeOH) λmax (log ε) 207 (3.10),
277 (2.44) nm; IR νmax 3423, 3005, 2942, 2845, 1700, 1611, 1510, 1463,
1427, 1337, 1228, 1188, 1110, 1076, 766 cmꢀ1; 1H NMR (pyridine-d5, 500
MHz) and 13C NMR (pyridine-d5, 125 MHz) are given in Table 3; (þ)-
ESIMS m/z535 [M þ Na]þ;(ꢀ)-ESIMSm/z511 [M ꢀ H]ꢀ;HRESIMS
m/z 511.1461 [M ꢀ H] ꢀ (calcd for C23H27O13, 511.1457).
7.18 s
7.40 brs
6.85 d (8.0)
7.46 dd (8.0, 1.5)
3.77 s
7.18 s
3.76 s
3.76 s
OMe
1-O-3,4-Dimethoxy-5-hydroxyphenyl-(6-O-vanilloyl)-β-D-glucopyra-
noside (10): white, amorphous powder; mp 127ꢀ128 °C; [R]20D ꢀ46.7
(c 0.04, MeOH); UV (MeOH) λmax (log ε) 208 (3.27), 263 (2.72), 292
(2.41) nm; IR νmax 3405, 3005, 2941, 2845, 1696, 1602, 1510, 1461, 1431,
1286, 1224, 1175, 1105, 1073, 765 cmꢀ1; 1H NMR (pyridine-d5, 500 MHz)
and 13C NMR (pyridine-d5, 125 MHz) are given in Table 3; (þ)-ESIMS
m/z 505 [M þ Na]þ; (ꢀ)-ESIMS m/z 481 [M ꢀ H]ꢀ; HRESIMS m/z
481.1354 [M ꢀ H]ꢀ (calcd for C22H25O12, 481.1351).
56.1
a Data assignments were based on HSQC and HMBC experiments.
(pyridine-d5, 125 MHz) are given in Tables 1 and 2, respectively; (þ)-
ESIMS m/z 1181 [M þ Na]þ; (ꢀ)-ESIMS m/z 1157 [M ꢀ H]ꢀ;
HRESIMS m/z 1181.5703 [M þ Na]þ (calcd for C57H90O24Na,
1181.5714).
Acid Hydrolysis and Sugar Analysis. The determination of the
absolute configuration of the sugars in compounds 1ꢀ10 was conducted
as described previously.3,4
Gordonoside J (2): white, amorphous powder; mp 239ꢀ240 °C;
[R]20D ꢀ4.8 (c 0.06 MeOH); UV (MeOH) λmax (log ε) 204 (4.28) nm;
IR νmax 3389, 2940, 1781, 1727, 1675, 1455, 1365, 1204, 1169, 1078,
1049 cmꢀ1; 1H NMR (pyridine-d5, 500 MHz) and 13C NMR (pyridine-
d5, 125 MHz) are given in Tables 1 and 2, respectively; (þ)-ESIMS m/z
1197 [M þ Na]þ; (ꢀ)-ESIMS m/z 1173 [M ꢀ H]ꢀ; HRESIMS m/z
1197.5668 [M þ Na]þ (calcd for C57H90O25Na, 1197.5663).
Gordonoside K (3): white, amorphous powder; mp 226ꢀ227 °C;
[R]20D ꢀ7.0 (c 0.13, MeOH); UV (MeOH) λmax (log ε) 204 (4.33) nm;
IR νmax 3383, 2939, 1730, 1673, 1445, 1363, 1256, 1204, 1142, 1073,
1047 cmꢀ1; 1H NMR (pyridine-d5, 500 MHz) and 13C NMR (pyridine-
d5, 125 MHz) are given in Tables 1 and 2, respectively; (þ)-ESIMS m/z
965 [M þ Na]þ; (ꢀ)-ESIMS m/z 941 [M ꢀ H]ꢀ; HRESIMS m/z
965.4697 [M þ Na]þ (calcd for C47H74O19Na, 965.4717).
Inhibitory Effects on Nitric Oxide Production in LPS-Activated
Macrophages. The procedure for NO determination was based on the
Griess reaction.8 One hundred microliters of culture supernatant or sodium
nitrite standard (5.2ꢀ103.6 μM) was mixed with an equal volume of Griess
reagent [a mixture of 0.1% (w/v) N-(1-naphthyl)ethylenediamine dihy-
drochloride and 1% (w/v) sulfanilamide in 5% (v/v) phosphoric acid; the
two parts being mixed together within 1 h of use] using a 96-well plate. After
20 min at room temperature, the absorbance at 540 nm was measured by a
microtitration plate reader.
’ ASSOCIATED CONTENT
Gordonoside L (4): white, amorphous powder; mp 234ꢀ235 °C;
[R]20D ꢀ9.3 (c 0.09, MeOH); UV (MeOH) λmax (log ε) 204 (4.27) nm;
IR νmax 3404, 2937, 1728, 1674, 1434, 1366, 1202, 1142, 1075, 1026 cmꢀ1;1H
NMR (pyridine-d5, 500 MHz) and 13C NMR (pyridine-d5, 125 MHz) are
given in Tables 1 and 2, respectively; (þ)-ESIMS m/z 1097 [M þ Na]þ;
HRESIMS m/z1097.5125 [M þ Na]þ (calcdforC52H82O23Na, 1097.5139).
Gordonoside M (5): white, amorphous powder; mp 235ꢀ236 °C;
S
Supporting Information. MS and 1D and 2D NMR
b
spectra of compounds 1ꢀ10. This material is available free of
’ AUTHOR INFORMATION
[R]20 ꢀ18.0 (c 0.03, MeOH); UV (MeOH) λmax (log ε) 204
Corresponding Author
*Tel: þ86-10-63165227. Fax: þ86-10-63165227. E-mail: zhangdm@
D
(4.32) nm; IR νmax 3404, 2943, 1728, 1675, 1435, 1388, 1365, 1203,
1142, 1074, 1049 cmꢀ1; H NMR (pyridine-d5, 500 MHz) and 13C
1
imm.ac.cn.
1071
dx.doi.org/10.1021/np200021f |J. Nat. Prod. 2011, 74, 1066–1072